Table 1

Patients’ characteristics at baseline

VariableN=33 patients
Age in years69.8±6.9
Sex
 Male12 (36.3%)
 Female21 (57.75%)
BMI25.8±4.4
Postbronchodilator spirometry*
 FEV1 (L)1±0.27
 FEV1 % of predicted41±13
 FVC (L)2.27±0.59
 FEV1/FVC, % of predicted43.9±12.47
GOLD classification*
 GOLD 10 (0%)
 GOLD 210 (30.3%)
 GOLD 314 (42.4%)
 GOLD 47 (21.2%)
Smoking pack years58.7±30.7
mMRC dyspnoea scale
 <36 (18.2%)
 ≥323 (69.7%)
CAT score18.15±7.25
Charlson comorbidity index4.8±1.2
Healthcare utilisation in the previous year
 Hospitalisations (≥1)7 (21.21%)
 Days hospitalised8.28±4.7
Depression assessment (PHQ-9)
 Minimal/mild depression25 (75.8%)
 Moderate/moderately severe depression8 (24.2%)
Anxiety classification (GAD7)
 None/mild25 (75.8%)
 Moderate/severe8 (24.2%)
  • Values are presented as n (%) or as mean±SD.

  • *Two missing postbronchodilator spirometry values.

  • BMI, body mass index; CAT, COPD assessment test; FEV1, forced expiratory volume in 1 s; FVC, forced vital capacity; GAD7, Generalised Anxiety Disorder 7; GOLD, global initiative for chronic obstructive lung disease; PHQ-9, Patient Health Questionnaire 9; mMRC, modified Medical Research Council.